Date: Jun 4, 2018 02:30 PM - 03:30 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Jun 04, 2018 10:30 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacist
Accreditation(s)

Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Registration Closed
Registration Closed
Objectives
- Describe the evidence for use of direct oral anticoagulants (DOACs) in cancer, kidney disease, and extreme weight patients.
- Identify key practical points for managing VTE in cancer, kidney disease, and extreme weight patients.
- Discuss appropriate care and monitoring plans for these patient populations.
Speaker(s)/Author(s)
Dhakrit Rungkitwattanakul, Pharm.D., Pharm.D
|
Activity Number
0010-0000-18-005-L01-P
Date:
06/04/18
Time:
02:30 PM - 03:30 PM
CE Hours
1.00
Registration Closed